Linical Future Growth
Future criteria checks 1/6
Linical is forecast to grow earnings and revenue by 9.1% and 2.6% per annum respectively. EPS is expected to decline by 0.4% per annum. Return on equity is forecast to be 8.1% in 3 years.
Key information
9.1%
Earnings growth rate
-0.4%
EPS growth rate
Life Sciences earnings growth | 24.8% |
Revenue growth rate | 2.6% |
Future return on equity | 8.1% |
Analyst coverage | Low |
Last updated | 17 Apr 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 13,500 | 680 | 734 | N/A | 1 |
3/31/2026 | 12,900 | 540 | 579 | N/A | 1 |
3/31/2025 | 12,300 | 400 | 699 | N/A | 1 |
3/31/2024 | 12,280 | 307 | 875 | N/A | 1 |
12/31/2023 | 12,518 | 680 | N/A | N/A | N/A |
9/30/2023 | 12,660 | 714 | 1,805 | 1,811 | N/A |
6/30/2023 | 12,730 | 931 | N/A | N/A | N/A |
3/31/2023 | 12,516 | 1,004 | 1,826 | 1,839 | N/A |
12/31/2022 | 12,188 | 843 | N/A | N/A | N/A |
9/30/2022 | 11,953 | 1,006 | 1,412 | 1,454 | N/A |
6/30/2022 | 11,639 | 799 | N/A | N/A | N/A |
3/31/2022 | 11,555 | 790 | 1,585 | 1,631 | N/A |
12/31/2021 | 11,360 | 906 | N/A | N/A | N/A |
9/30/2021 | 10,820 | 804 | 1,289 | 1,343 | N/A |
6/30/2021 | 10,639 | 805 | N/A | N/A | N/A |
3/31/2021 | 10,279 | 539 | -45 | 23 | N/A |
12/31/2020 | 10,262 | 241 | N/A | N/A | N/A |
9/30/2020 | 10,527 | 239 | 61 | 127 | N/A |
6/30/2020 | 10,679 | 268 | N/A | N/A | N/A |
3/31/2020 | 10,935 | 482 | 1,061 | 1,192 | N/A |
12/31/2019 | 10,944 | 508 | N/A | N/A | N/A |
9/30/2019 | 11,090 | 409 | 104 | 201 | N/A |
6/30/2019 | 11,234 | 541 | N/A | N/A | N/A |
3/31/2019 | 11,313 | 568 | -852 | -796 | N/A |
12/31/2018 | 10,975 | 853 | N/A | N/A | N/A |
9/30/2018 | 10,406 | 1,147 | 446 | 515 | N/A |
6/30/2018 | 9,736 | 1,177 | N/A | N/A | N/A |
3/31/2018 | 9,113 | 1,295 | 1,262 | 1,360 | N/A |
12/31/2017 | 8,870 | 1,281 | N/A | N/A | N/A |
9/30/2017 | 8,645 | 1,237 | N/A | 2,133 | N/A |
6/30/2017 | 8,541 | 1,381 | N/A | N/A | N/A |
3/31/2017 | 8,355 | 1,447 | N/A | 2,291 | N/A |
12/31/2016 | 8,131 | 1,375 | N/A | N/A | N/A |
9/30/2016 | 7,916 | 1,331 | N/A | 1,173 | N/A |
6/30/2016 | 7,891 | 1,368 | N/A | N/A | N/A |
3/31/2016 | 7,666 | 1,330 | N/A | 1,817 | N/A |
12/31/2015 | 7,420 | 1,154 | N/A | N/A | N/A |
9/30/2015 | 6,644 | 1,015 | N/A | 1,775 | N/A |
6/30/2015 | 5,549 | 579 | N/A | N/A | N/A |
3/31/2015 | 4,872 | 437 | N/A | 690 | N/A |
12/31/2014 | 4,231 | 465 | N/A | 597 | N/A |
9/30/2014 | 4,022 | 429 | N/A | 437 | N/A |
6/30/2014 | 3,909 | 445 | N/A | 480 | N/A |
3/31/2014 | 3,721 | 449 | N/A | 249 | N/A |
12/31/2013 | 3,692 | 473 | N/A | 195 | N/A |
9/30/2013 | 3,582 | 481 | N/A | 332 | N/A |
6/30/2013 | 3,551 | 515 | N/A | 705 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2183's forecast earnings growth (9.1% per year) is above the savings rate (0.2%).
Earnings vs Market: 2183's earnings (9.1% per year) are forecast to grow slower than the JP market (9.4% per year).
High Growth Earnings: 2183's earnings are forecast to grow, but not significantly.
Revenue vs Market: 2183's revenue (2.6% per year) is forecast to grow slower than the JP market (4.4% per year).
High Growth Revenue: 2183's revenue (2.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2183's Return on Equity is forecast to be low in 3 years time (8.1%).